Source: Live Report
On December 21, 7 domestic companies were approved with a “filing notice” on December 20 to obtain the pre-conditions for overseas listing, namely: Outbound Enquiry, Walker Healthcare, Robey Electric Vehicle, Yidayun, Yiteng Pharmaceutical, Hardening Technology, and Tea Baidao. 4 went public in Hong Kong, and 3 went public in the US.
4 listed companies in Hong Kong:
The Outbound Questionnaire was filed with the China Securities Regulatory Commission on June 8. The application type is indirect overseas listing. The proposed listing on the Hong Kong Stock Exchange is 195 days.
Yi Dayun filed a record with the China Securities Regulatory Commission on July 17. The application type is indirect overseas listing. The proposed listing on the Hong Kong Stock Exchange is 156 days.
Yiteng Pharmaceutical filed a record with the China Securities Regulatory Commission on July 18. The application type is indirect overseas listing. It is proposed to be listed on the Hong Kong Stock Exchange. The approval period is 155 days.
Cha Baidao filed a filing with the China Securities Regulatory Commission on August 25. The application type is direct overseas listing (including full circulation). It is proposed to be listed on the Hong Kong Stock Exchange and about 1.33 billion unlisted domestic shares of 14 shareholders will be converted to overseas listed shares for full circulation. The approval period is 117 days.
3 companies listed in the US:
Walker Healthcare filed a record with the China Securities Regulatory Commission on June 27. The application type is indirect overseas listing. It is proposed to be listed on the Nasdaq Exchange. The approval period is 176 days.
Robey Electric Vehicle was registered with the China Securities Regulatory Commission on July 10. The application type is indirect overseas listing. It is proposed to be listed on the Nasdaq Exchange. The approval period is 163 days.
Hardening Technology was registered with the China Securities Regulatory Commission on August 7. The application type is indirect overseas listing. It is proposed to be listed on the Nasdaq Exchange. The approval period is 135 days.
As of December 20, a total of 78 domestic enterprises have completed the China Securities Regulatory Commission filing process.